MNV
Market News Video
MNV MNV 10 Stocks Crossing Below Book Value
MNV
MNV
MNV
MNV
MNV
MNV
MNV
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

First Week of CRSP January 2026 Options Trading
Tuesday, September 12, 11:24 AM ET, by Market News Video Staff

Investors in CRISPR Therapeutics AG (CRSP) saw new options become available this week, for the ...

Implied ESGV Analyst Target Price: $90
Friday, September 22, 6:46 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

CRISPR Therapeutics is Now Oversold (CRSP)
Friday, October 20, 12:03 PM ET, by Market News Video Staff

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...

Analysts Anticipate ANEW To Hit $41
Thursday, October 26, 7:18 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

December 22nd Options Now Available For CRISPR Therapeutics (CRSP)
Thursday, November 2, 11:45 AM ET, by Market News Video Staff

Investors in CRISPR Therapeutics AG (CRSP) saw new options begin trading today, for the December ...

RSI Alert: CRISPR Therapeutics (CRSP) Now Oversold

By Market News Video Staff, Monday, August 7, 12:38 PM ET
Play Video: Learn About The RSI


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Email EnvelopeFree Email Alerts By Stock:
Get Dividend Alerts
Get SEC Filing Alerts

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In trading on Monday, shares of CRISPR Therapeutics AG (NASDAQ:CRSP) entered into oversold territory, hitting an RSI reading of 29.2, after changing hands as low as $48.90 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 51.6. A bullish investor could look at CRSP's 29.2 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of CRSP shares:

CRISPR Therapeutics AG 1 Year Performance Chart

Looking at the chart above, CRSP's low point in its 52 week range is $38.94 per share, with $84.10 as the 52 week high point — that compares with a last trade of $48.86. Find out what 9 other oversold stocks you need to know about »


Special Offer: Join the income investing conversation on ValueForum.com with a special Seven Days for Seven Dollars invitation.


This Article's Word Cloud:   About   Buffett   CRSP   Days   Dollars   Find   Index   Join   Know   Legendary   Looking   Monday   Offer   Oversold   Relative   Seven   Should   Special   Start   Stocks   Strength   Therapeutics   ValueForum   Warren   about   above   advises   after   analysis   begin   below   bullish   called   chart   fearful   greedy   investor   look   others   oversold   point   raquo   reading   share   shares   stock   that   week   when   with
MNV
MNV
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use - Privacy Policy
MNV
Home  |  Analyst News  Dividend Report  ETFs  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV
MNV MNV Portfolio Channel Stock Market Definitions
MNV

RSI Alert: CRISPR Therapeutics (CRSP) Now Oversold | Market News Video | Copyright © 2008 - 2024, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.

X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.